Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma
- 1 October 1992
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 340 (8827), 1049-1052
- https://doi.org/10.1016/0140-6736(92)93075-x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Effects of amino-butylidene diphosphonate in hypercalcemia due to malignancyBone, 1991
- LONG-TERM EFFECTS OF PARENTERAL DICHLOROMETHYLENE BISPHOSPHONATE (CL2MBP) ON BONE DISEASE OF MYELOMA PATIENTS TREATED WITH CHEMOTHERAPYHematological Oncology, 1990
- Clodronate. A randomized study in the treatment of cancer-related hypercalcemiaArchives of Internal Medicine, 1987
- The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myelomaBritish Journal of Haematology, 1983
- Long-Term Effects of Dichloromethylene Diphosphonate (Cl2 DP) on skeletal Lesions in Multiple MyelomaMetabolic Bone Disease and Related Research, 1982
- Bone histomorphometry in pacet's disease quantitative and dynamic analysis of pagetic and nonpagetic bone tissueArthritis & Rheumatism, 1980
- Biochemical and clinical responses to dichloromethylene diphosphonate (cl2mdp) in paget's disease of boneArthritis & Rheumatism, 1980
- Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.Journal of Clinical Investigation, 1980
- Effects of Dichloromethylene Diphosphonate on Skeletal Mobilization of Calcium in Multiple MyelomaNew England Journal of Medicine, 1980
- A computer program for comparing K samples with right-censored dataComputer Programs in Biomedicine, 1972